Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ · Healthcare
Arcturus Therapeutics Holdings Inc. Price to FCF Ratio 2013–2026
Price to free cash flow (P/FCF) ratio for Arcturus Therapeutics Holdings Inc. (ARCT): market cap divided by trailing twelve-month free cash flow. As of September 30, 2023 it is 27.98.
From: 06/30/2019To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Arcturus Therapeutics Holdings Inc. Price to FCF Ratio — FAQ
Arcturus Therapeutics Holdings Inc. (ARCT) price to fcf ratio over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARCT's price to fcf ratio history?
The chart and table above show Arcturus Therapeutics Holdings Inc.'s price to fcf ratio by year and by quarter, including the growth rate.